Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05818891

Multicenter Mpact DM France

Conditions: Total Hip Arthroplasty, Survival, Prosthesis

Sex: All
Ages: 18 Years – 80 Years
Healthy volunteers: No
Enrollment: 600
Sponsor: Medacta International SA

Location: Centre Orthopédique Médico-Chirurgical de Dracy Le Fort Dracy-le-Fort

Summary

The primary objective of the study is to evaluate the 10-year performance of the MPACT DM cup in the treatment of patients requiring total hip arthroplasty. The primary endpoint is the 10-year life span of the prosthesis according to the Kaplan Meier curve.

Eligibility Criteria

Inclusion Criteria: 1. Patient with a disease that meets the indications for use of Medacta implants (according to the instructions for use) 2. Patient eligible for first-line total hip replacement 3. Patient between 18 and 80 years of age 4. Patient covered by the Social Security system or an equivalent protection plan 5. Patient who is capable, in the opinion of the investigator, of fulfilling the requirements of the study Exclusion Criteria: 1. Patient requiring a transplant 2. Patient with progressive local or systemic infection 3. Patient with muscle loss, neuromuscular disease, or vascular impairment of the affected limb making surgery unwarranted 4. Patient with known medical problems that may compromise independent recovery of mobility 5. Patient with a BMI greater than 40 kg/m². 6. Patient with major cognitive problems that do not allow a good understanding of the study requirements 7. Patient living in a geographical area that does not allow the study follow-up 8. Patient participating in interventional research. 9. Minor patient 10. Protected adult patient 11. Vulnerable person according to article L1121-6 of the Public Health Code 12. Pregnant or nursing woman.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05818891). StuddyBuddy aggregates publicly available trial information.